Medicine composition for treating xerophthalmia and preparation method and application thereof

Abstract

The invention discloses a medicine composition for treating xerophthalmia. The medicine composition is a preparation prepared from the following crude drugs in weight ratio: 12-18 parts of rhizoma polygonati, 8-12 parts of radix glehniae, 8-12 parts of medlar and 8-12 parts of chrysanthemum. According to the medicine composition disclosed by the invention, the rhizoma polygonati, the radix glehniae, the medlar and the chrysanthemum are reasonably combined, and thus, symptoms, such as dryness, foreign body sensation and hyperemia of bulbar conjunctiva of eyes, can be obviously improved. The medicine composition can be effectively used for treating xerophthalmia caused by video terminals, middle-aged and elderly xerophthalmia or diabetic xerophthalmia. Moreover, the clinical effect of the medicine composition is obviously superior to that of the Western medicine Tears Natural II group and the traditional Chinese medical science acupuncture group. The medicine composition is high in safety and good economic benefit, and a new medicine selection is provided for clinically treating the xerophthalmia.

Description

technical field [0001] The invention relates to a pharmaceutical composition for treating dry eye, its preparation method and application. Background technique [0002] With the development of society and the acceleration of the pace of life, dry eye has become a common, frequently-occurring, and refractory disease in ophthalmology. Dry eye syndrome has complicated etiology and complicated pathological process. It is a common ocular surface disease in ophthalmology. The patient's tear secretion is significantly reduced or the tear composition is abnormal, the tear film breakup time is shortened, the corneal epithelium is punctate, and the fluorescein staining is positive. Since the tear film can no longer assume its barrier, immunomodulatory, and mechanical detritus removal and antimicrobial roles, the sensory nerve-rich cornea is directly exposed to the outside world, plus viscous debris deposited in the conjunctival sac and filamentous corneal exfoliation Epithelial stimu...

AI Technical Summary

Problems solved by technology

[0004] However, among the currently reported drugs for the treatment of dry eye syndrome, there are many medicinal materials in the prescription and the cost is high, which is not conducive to the long-term use of patients.

At present, there is no report on the treatment of dry eye syndrome with only the four herbs of Rhizoma Polygonatum, Radix Glycyrrhizae, Lycium barbarum, and Chrysanthemum.

Images